User menu

Phase 2 Open-Label study of MEDI-551 and Bendamustine vs Rituximab and Bendamustine in Adults With Relapsed or Refractory CLL

Bibliographic reference Gladstone, D ; André, Marc ; Zaucha, J ; Assouline, S ; Bellam, N ; et. al. Phase 2 Open-Label study of MEDI-551 and Bendamustine vs Rituximab and Bendamustine in Adults With Relapsed or Refractory CLL.50th Annual Meeting of the American Society if Clinical Oncology (Chicago, du 30/05/2014 au 03/06/2014).
Permanent URL http://hdl.handle.net/2078.1/145685